|
Benderradji H, Kraiem S, Courty E, Eddarkaoui S, Bourouh C, Faivre E, Rolland L, Caron E, Besegher M, Oger F, Boschetti T, Carvalho K, Thiroux B, Gauvrit T, Nicolas E, Gomez-Murcia V, Bogdanova A, Bongiovanni A, Muhr-Tailleux A, Lancel S, Bantubungi K, Sergeant N, Annicotte JS, Buee L, Vieau D, Blum D, Buee-Scherrer V. Impaired Glucose Homeostasis in a Tau Knock-In Mouse Model. Front Mol Neurosci. 2022 Feb 16;15:841892. doi: 10.3389/fnmol.2022.841892. eCollection 2022. PubMed PMID: 35250480; PubMed Central PMCID: PMC8889017.
AÑO: 2022; IF: 4.8
|
35250480
|
Dewaeles E, Carvalho K, Fellah S, Sim J, Boukrout N, Caillierez R, Ramakrishnan H, Van der Hauwaert C, Vijaya Shankara J, Martin N, Massri N, Launay A, Folger JK, de Schutter C, Larrue R, Loison I, Goujon M, Jung M, Le Gras S, Gomez-Murcia V, Faivre E, Lemaire J, Garat A, Beauval N, Maboudou P, Gnemmi V, Gibier JB, Buee L, Abbadie C, Glowacki F, Pottier N, Perrais M, Cunha RA, Annicotte JS, Laumet G, Blum D, Cauffiez C. Istradefylline protects from cisplatin-induced nephrotoxicity and peripheral neuropathy while preserving cisplatin antitumor effects. J Clin Invest. 2022 Nov 15;132(22):e152924. doi: 10.1172/JCI152924. PubMed PMID: 36377661; PubMed Central PMCID: PMC9663157.
AÑO: 2022; IF: 15.9
|
|
Gomez-Murcia V, Carvalho K, Thiroux B, Caillierez R, Besegher M, Sergeant N, Buee L, Faivre E, Blum D. Impact of chronic doxycycline treatment in the APP/PS1 mouse model of Alzheimer's disease. Neuropharmacology. 2022 May 15;209:108999. doi: 10.1016/j.neuropharm.2022.108999. Epub 2022 Feb 15. PubMed PMID: 35181375.
AÑO: 2022; IF: 4.7
|
|
Navarro-Zaragoza J, Martinez-Laorden E, Teruel-Fernandez FJ, Gomez-Murcia V, Canovas A, Milanes MV, Laorden ML, Almela P. Naloxone-induced conditioned place aversion score and extinction period are higher in C57BL/6J morphine-dependent mice than in Swiss: Role of HPA axis. Pharmacol Biochem Behav. 2021 Feb;201:173106. doi: 10.1016/j.pbb.2021.173106. Epub 2021 Jan 12. PubMed PMID: 33444599.
AÑO: 2021; IF: 3.697
|
|
Brigas HC, Ribeiro M, Coelho JE, Gomes R, Gomez-Murcia V, Carvalho K, Faivre E, Costa-Pereira S, Darrigues J, de Almeida AA, Buee L, Dunot J, Marie H, Pousinha PA, Blum D, Silva-Santos B, Lopes LV, Ribot JC. IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer's disease. Cell Rep. 2021 Aug 31;36(9):109574. doi: 10.1016/j.celrep.2021.109574. PubMed PMID: 34469732.
AÑO: 2021; IF: 9.995
|